FDA action counts
| Total FDA actions | 3 |
|---|---|
| Warning letters | 0 |
| Recalls | 2 |
| Approval records | 0 |
| Form 483 inspection citations | 1 |
| Most recent action | June 24, 2026 |
Enforcement history
On 2026-05-27, Argus HQ recorded a FDA recall for IntegraDose Compounding Services LLC, rated "high" severity in Argus HQ's classification: IntegraDose Compounding Services LLC — Class II recall: fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water,… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-24, Argus HQ recorded a FDA recall for IntegraDose Compounding Services LLC, rated "high" severity in Argus HQ's classification: IntegraDose Compounding Services LLC — Class II recall: Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compoundi… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. In total, IntegraDose Compounding Services LLC has 2 FDA events on file with Argus HQ across the sources Argus HQ currently tracks (FDA Warning Letters, recalls, drug/biologic approvals, and Form 483 inspection observations). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Counting an FDA record here does not by itself indicate an unresolved problem -- warning letters, recalls, and inspection observations are frequently closed out once a firm completes FDA-required corrective action.
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. IntegraDose Compounding Services LLC has 2 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Frequently asked questions
- Does Argus HQ track new FDA actions for IntegraDose Compounding Services LLC automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to IntegraDose Compounding Services LLC is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for IntegraDose Compounding Services LLC?
- 3 total: 0 warning letters, 2 recalls, 0 approval records, and 1 Form 483 inspection citation.
- What is the most recent FDA action on file for IntegraDose Compounding Services LLC?
- June 24, 2026. Argus HQ ingests new FDA enforcement records daily.
- Has IntegraDose Compounding Services LLC had product recalls?
- Yes, 2 recalls on file. See the full history below for each one.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
- IntegraDose Compounding Services LLC — Class II recall: Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compoundi… →
- IntegraDose Compounding Services LLC — Class II recall: fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water,… →
- IntegraDose Compounding Services LLC -- FDA 483: 3 observations (2025-07-25) →
Compare with
- IntegraDose Compounding Services LLC vs Medline Industries, LP
- IntegraDose Compounding Services LLC vs ARROW INTERNATIONAL, LLC
- IntegraDose Compounding Services LLC vs Stryker Sustainability Solutions
- IntegraDose Compounding Services LLC vs Guardian Drug Co. Inc.
- IntegraDose Compounding Services LLC vs B BRAUN MEDICAL INC
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Regulatory Record: IntegraDose Compounding Services LLC. Digital Empire LLC. Retrieved from https://argushq.ai/company/integradose-compounding-services-llc
"Regulatory Record: IntegraDose Compounding Services LLC." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/integradose-compounding-services-llc.
Argus HQ Research. "Regulatory Record: IntegraDose Compounding Services LLC." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/integradose-compounding-services-llc.
@misc{argushq_argushq_ai_company_integradose_compounding_services_llc_2026,
title = {Regulatory Record: IntegraDose Compounding Services LLC},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/company/integradose-compounding-services-llc},
note = {Accessed: July 13, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗

